Eyenovia Announces FDA Acceptance of IND Application for MicroPine to Reduce the Progression of Myopia

Stock Information for Eyenovia Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Eyenovia Inc.

Eyenovia Reports Second Quarter 2019 Financial Results
Eyenovia Announces Conference Call and Webcast for Second Quarter 2019 Financial Results
Eyenovia, Inc. Announces Underwriters' Full Exercise of Over-Allotment Option in Public Offering
Eyenovia, Inc. Announces Closing of Public Offering
Eyenovia, Inc. Prices Public Offering of Common Stock
Eyenovia, Inc. Announces Proposed Public Offering of Common Stock
Eyenovia Enrolls First Patient in Phase III CHAPERONE Study for Progressive Myopia
Eyenovia Reports First Quarter 2019 Financial Results

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.